Sandor L. Varga
9Patents
4h-index
20Co-inventors
53Inventor score
Filing activity: Jan 27, 1975 → Oct 15, 1992
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5288725A | Pyrroloquinoline Bradykinin antagonist | Chemistry; Metallurgy | 28 | Expired |
| US3959248A | Analogs of thyrotropin-releasing hormone | Chemistry; Metallurgy | 17 | Expired |
| US4439359A | Cyclic octapeptide analogs of neurotensin | Emerging Cross-Sectional Technologies | 9 | Expired |
| US4425269A | Metabolically protected analogs of neurotensin | Human Necessities | 8 | Expired |
| US4593039A | 1-aryloxy-3-(substituted aminoalkylamino)-2-propanols | Chemistry; Metallurgy | 4 | Expired |
| US4108987A | Cyclic hexapeptides | Emerging Cross-Sectional Technologies | 4 | Expired |
| US4870079A | Derivatives of 5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine | Chemistry; Metallurgy | 3 | Expired |
| US4946859A | 4-(2-methyl-2-hydroxypropylamino)-5,6-dihydrot hieno-[2,3-b]thiopyran-2-sulfonamide-7,7-dioxide | Human Necessities | 2 | Expired |
| US4810725A | 1-aryloxy-3-(substituted aminoalkylamino)-2-propanols, pharmaceutical compositions and use | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.